Innate Pharma (IPH) — Free Cash Flow Generation Index
Innate Pharma (IPH) has a Free Cash Flow Generation Index of 0.91x as of June 2024. Free cash flow of €2.75 Million represents 1% of operating cash flow (€3.04 Million). Explore Innate Pharma (IPH) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Innate Pharma Free Cash Flow Generation Index (2006–2019)
Historical FCF Generation Index trend for Innate Pharma across 4 annual periods. For the full cash flow conversion analysis, see IPH operating cash flow.
Annual Free Cash Flow Generation for Innate Pharma (2006–2019)
Year-by-year Free Cash Flow Generation Index for Innate Pharma. Check Innate Pharma total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | -0.87x | €-30.48 Million | €34.92 Million | €65.40 Million | ▼ -190.5% |
| 2015 | 0.96x | €200.51 Million | €207.91 Million | €7.40 Million | ▼ -1.1% |
| 2011 | 0.98x | €12.66 Million | €12.99 Million | €322.00K | ▲ +189.6% |
| 2006 | -1.09x | €-392.00K | €360.00K | €752.00K | — |